S07-1066

• Target :

  Dehydrogenase|||Others

• Related Pathways :

  Others|||Metabolism

• Bioactivity :

  S07-1066, an aldo-keto reductase 1C3 (AKR1C3) inhibitor, enhances doxorubicin (DOX) cytotoxicity by selectively inhibiting AKR1C3-mediated reduction of DOX and reversing DOX resistance in cells with elevated AKR1C3 expression [1].

• Smiles :

  O=C(O)C1(C=2C=CC(=C(F)C2)C3=CC(Cl)=CC(Cl)=C3)CC1

• Molecular Formula :

  C16H11Cl2FO2

• Molecular Weight :

  325.16

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  876625-29-5